Singulair Suicide

Guide Note:

The Food and Drug Administration (FDA) is investigating a possible link between the drug Singulair and Suicide. It could take up to nine months for a complete safety review on the drug. The drug, developed and produced by Merck, was approved in 1998 for treating asthma symptoms and further endorsed for seasonal allergy symptoms in 2003. It's estimated that millions of people have since taken the medication.

The family of 15-year-old Cody Miller, who killed himself on August 4, 2007 after taking Singulair for just 17 days, is alleging that the drug's effects are responsible for their son's death. He had previously been taking competitor Allegra before his pediatrician encouraged a switch. Shortly after Miller's death, Merck added "suicidal behavior" to the list of potential Singulair side effects.

Fast Facts:

  1. Available only by prescription
  2. Merck paid out an $4.85 billion settlement after painkiller Vioxx was shown to cause heart attacks and strokes

Singulair Suicide News

  • The New York Times: FDA Investigates Suicide With Merck Drug (March 27, 2008) WARNING: Pop-up ad
    • The FDA inquiry, according to Merck, is based on anecdotal reports and not clinical trials. Studies are typically used to evaluate drug safety, and the company claims that none of the subjects in any of the 40 separate studies run on Singulair committed suicide.

Related Searches

Singulair | Merck | Asthma | Vioxx | Vioxx Settlement


  • Singulair Suicide is currently a stub, a brief collection of the best links for this story. The page will be updated as we find more information.
  • Help Mahalo complete this search! Let us know if you've found additional quality links about Singulair Suicide on Google, Del.icio.us, Digg or elsewhere, and we can expand this result.